Curanex Pharmaceuticals CURX Growth Metrics (2024-2026)

NASDAQ CURX
$5.01 +0.39 (+8.43%)
As of: Oct 21, 2026 · 2:44 PM EDT
Reported Financials

Curanex Pharmaceuticals Quarterly Growth Metrics

Periods 6 quarters
Latest Jun 2026

Curanex Pharmaceuticals reported asset growth of 544.58% for the quarter ended Jun 2026. These growth metrics cover 6 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Sep2024 Dec2024 Jun2025 Sep2025 Dec2025 Jun2026
Growth Ratios
Assets Growth (1y) 2,135.83%544.58%
Assets (QoQ) 1,739.26%-20.02%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) -70.91%2,286.46%3,240.12%2,599.26%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -34.72%-39.06%5,255.90%-14.71%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -6,970.04%-798.49%
Cash from Operations (QoQ)Cash from Ops. (QoQ) 26.56%90.67%
EBIT Growth (1y) -30.45%-919.70%-1,998.61%-5,667.73%
EBIT (QoQ) -111.07%-57.96%-1,549.95%-225.09%
EBT Growth (1y) -37.44%-924.08%-1,998.61%-5,374.26%
EBT (QoQ) -111.07%-57.96%-1,472.73%-223.70%
EPS (Basic) Growth (1y) 86.35%-71.69%-995.03%-4,514.31%
EPS (Basic) (QoQ) -17.86%49.29%-1,382.19%-223.40%
EPS (Diluted) Growth (1y) 86.35%-71.69%-995.03%-4,514.31%
EPS (Diluted) (QoQ) -17.86%49.29%-1,382.19%-223.40%
Free Cash Flow Growth (1y)FCF Growth (1y) -6,970.04%-798.49%
Free Cash Flow (QoQ)FCF (QoQ) 26.56%90.67%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ) -1,146.94%
Net Cash Flow Growth (1y)NCF Growth (1y) 4,503.22%-798.49%
Net Cash Flow (QoQ)NCF (QoQ) 26.56%-114.99%
Net Income Growth (1y) -36.53%-946.51%-2,005.76%-5,353.50%
Net Income (QoQ) -106.26%-60.08%-1,480.98%-222.11%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -36.53%-946.51%-2,005.76%-5,353.50%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -106.26%-60.08%-1,480.98%-222.11%
Operating Income Growth (1y)Op. Inc Growth (1y) -30.45%-919.70%-1,998.61%-5,667.73%
Operating Income (QoQ)Op. Inc (QoQ) -111.07%-57.96%-1,549.95%-225.09%
Profit After Tax Growth (1y)PAT Growth (1y) -37.44%-924.08%-1,998.61%-5,374.26%
Profit After Tax (QoQ)PAT (QoQ) -111.07%-57.96%-1,472.73%-223.70%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.00M0.00M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) 0.00M0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y) -743.00
Return on Equity [ROE] (QoQ)ROE (QoQ) 0.01M0.00M

Curanex Pharmaceuticals Growth Metrics API

Pull Curanex Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CURX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY